Symbol="MYGN"
AssetType="Common Stock"
Name="Myriad Genetics Inc"
Description="Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The company is headquartered in Salt Lake City, Utah."
CIK="899923"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES"
Address="320 WAKARA WAY, SALT LAKE CITY, UT, US"
FiscalYearEnd="June"
LatestQuarter="2023-06-30"
MarketCapitalization="1452611000"
EBITDA="-119900000"
PERatio="None"
PEGRatio="1.11"
BookValue="8.98"
DividendPerShare="0"
DividendYield="0"
EPS="-3.17"
RevenuePerShareTTM="8.61"
ProfitMargin="-0.355"
OperatingMarginTTM="-0.257"
ReturnOnAssetsTTM="-0.0935"
ReturnOnEquityTTM="-0.295"
RevenueTTM="698900000"
GrossProfitTTM="476400000"
DilutedEPSTTM="-3.17"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.023"
AnalystTargetPrice="21.72"
TrailingPE="-"
ForwardPE="40.98"
PriceToSalesRatioTTM="2.15"
PriceToBookRatio="1.666"
EVToRevenue="2.224"
EVToEBITDA="-19.13"
Beta="1.775"
num_52WeekHigh="24.93"
num_52WeekLow="13.92"
num_50DayMovingAverage="21.5"
num_200DayMovingAverage="20.39"
SharesOutstanding="81883000"
DividendDate="None"
ExDividendDate="None"
symbol="MYGN"
open="17.80"
high="17.93"
low="17.12"
price="17.37"
volume="299146.00"
latest_trading_day="2023-08-22"
previous_close="17.74"
change="-0.37"
change_percent="-2.0857%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="34"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="66"
Volume_recent_avg="526071"
Change_recent_avg="-0.04"
Delta_recent_avg="0.88"
Variance_recent_avg="0.44"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="66"
Aroon_momentum_negative="34"
image_negative_thumbnail_id_1="146"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0030.jpeg"
image_negative_thumbnail_id_2="499"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0106.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="608"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0100.jpeg"
image_positive_thumbnail_id_2="970"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0132.jpeg"
image_professor_thumbnail_id_1="1203"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
